High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

Blood

Volumn 85, Issue 6, 1995, Pages 1504-1508

  Rosendaal, F R ^a   Koster, T ^a   Vandenbroucke, J P ^a   Reitsma, P H ^a  

^a C0 P ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 0028931717     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.6.1504.bloodjournal8561504     Document Type: Article

References (14)

1. Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
2. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
3. Rosendaal FR, Bertina RM, Reitsma PH: Evaluation of activated protein C resistance in stored plasma. Lancet 343:1289, 1994
4. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503, 1993
5. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517, 1994
6. Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 19:251, 1955
7. Greenland S: Multivariate estimation of exposure-specific incidence from case-control studies. J Chron Dis 34:445, 1981
8. Grizzle JE, Starmer CF, Koch GG: Analysis of categorical data by linear models. Biometrics 25:489, 1969
9. Briët E, van der Meer FJM, Rosendaal FR, Houwing-Duistermaat JJ, van Houwelingen JC: The family history and inherited thrombophilia. Br J Haematol 87:348, 1994
10. Branson HE, Marble R, Katz J, Griffin JH: Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 2:1165, 1983
11. Mahasandana C, Suvatte V, Marlar RA, Johnson MJ, Jacobson LJ, Hathaway WE: Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 335:61, 1990
12. Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR: Increased risk of venous thrombosis in oralcontraceptive users who are carriers of factor V Leiden mutation. Lancet 344:1453, 1994
13. Rothman KJ: Modern Epidemiology. Boston, MA, Little, Brown and Company, 1986, p 311
14. Koster T, Rosendaal FR, van der Meer FJM, Briët E, Vandenbroucke JP: More objective diagnoses of venous thromboembolism? Neth J Med 38:246, 1991